Last update:

High-dose vitamin D may improve cognition among those at risk of dementia, study finds

With more than 7 million Americans living with Alzheimer's dementia—a number projected to reach nearly 13 million by 2050—new Emory University research suggests that higher vitamin D supplement intake may be associated with ...

AI-calculated brain age predicts dementia risk years before doctors can see it

Memory clinics still rely on visual rating scales to assess brain atrophy, yet these tools lack the sensitivity to catch subtle changes associated with early dementia. A measure of how old a person's brain appears on brain ...

Medical research news

Ambient light activates wearable patch for wound treatment

A research team has developed a wearable patch that simultaneously promotes wound closure and tissue regeneration using room light or sunlight, without batteries or an external electrical power source. The work has been published ...

Does your immune system learn like AI?

Could AI hold the key to answering questions that have stumped doctors and scientists for decades? A recent study at Cold Spring Harbor Laboratory (CSHL) borrows concepts from machine learning to address an age-old riddle ...

Newly found 'immune organ' inside skull directs brain defense

Researchers at Washington University School of Medicine in St. Louis have discovered lymph node-like structures in the skull bone marrow of mice for the first time and demonstrated that they act as rapid first responders ...

Why do we get sleepy? How neurons control sleep drive

Why does staying awake inevitably make us sleepy? Researchers at the University of Basel, Switzerland, have identified neuronal populations in the brains of mice that become activated during prolonged wakefulness and are ...

GLP-1 diabetes drugs linked to up to 68% higher hair loss risk

The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. ...

New therapeutic target expands options for multiple myeloma

In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...

Human study links reduced inflammation to later myopia onset

University of Oklahoma College of Medicine researcher Jody Summers, Ph.D., has long hypothesized that inflammation plays a role in the development of myopia, or nearsightedness, in which close-up vision is clear but distance ...

Exercise addiction is real, but often overstated

With fitness culture booming and "no days off" mindsets trending, new research is challenging common assumptions about "exercise addiction"—finding that the issue is real but often misunderstood and overstated.